-
1
-
-
0003379858
-
Arimidex, Tamoxifen, Alone or in Combination (ATAC) adjuvant trial in post-menopausal breast cancer
-
Abstract 99
-
Baum M & Houghton J on behalf of the ATAC Steering Committee, UK 1998 Arimidex, Tamoxifen, Alone or in Combination (ATAC) adjuvant trial in post-menopausal breast cancer. European Journal of Cancer 34 (Suppl 1) S39 Abstract 99.
-
(1998)
European Journal of Cancer
, vol.34
, Issue.1 SUPPL.
-
-
Baum, M.1
Houghton, J.2
-
2
-
-
0010474727
-
Significant improved survival with Arimidex (Anastrozole) vs megestrol acetate in postmenopausal advanced breast cancer: Updated results of two randomised trials
-
Abstract 545
-
Buzdar A, Jonat W, Howell A et al. 1997 Significant improved survival with Arimidex (Anastrozole) vs megestrol acetate in postmenopausal advanced breast cancer: updated results of two randomised trials. Proceedings of ASCO, 33rd Annual Meeting, Abstract 545.
-
(1997)
Proceedings of ASCO, 33rd Annual Meeting
-
-
Buzdar, A.1
Jonat, W.2
Howell, A.3
-
3
-
-
0023197282
-
Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer
-
Coombes RC, Powles TJ, Easton D et al. 1987 Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer. Cancer Research 47 2494-2497.
-
(1987)
Cancer Research
, vol.47
, pp. 2494-2497
-
-
Coombes, R.C.1
Powles, T.J.2
Easton, D.3
-
4
-
-
0026666565
-
4-Hydroxyandrostenedione: A new treatment for postmenopausal patients with breast cancer
-
Coombes RC, Hughes SW & Dowsett M 1992 4-Hydroxyandrostenedione: a new treatment for postmenopausal patients with breast cancer. European Journal of Cancer 28A 1941-1945.
-
(1992)
European Journal of Cancer
, vol.28 A
, pp. 1941-1945
-
-
Coombes, R.C.1
Hughes, S.W.2
Dowsett, M.3
-
5
-
-
0028609997
-
Tamoxifen withdrawal responses: Chance observations or clinical clues to antioestrogen resistance?
-
DeFriend DJ & Howell A 1994 Tamoxifen withdrawal responses: chance observations or clinical clues to antioestrogen resistance? Breast 3 199-201.
-
(1994)
Breast
, vol.3
, pp. 199-201
-
-
DeFriend, D.J.1
Howell, A.2
-
6
-
-
0026764412
-
Long-term effects of tamoxifen on blood lipid values in breast cancer
-
Dewar JA, Horobin JM, Preece PE et al 1992 Long-term effects of tamoxifen on blood lipid values in breast cancer. British Medical Journal 305 225-226.
-
(1992)
British Medical Journal
, vol.305
, pp. 225-226
-
-
Dewar, J.A.1
Horobin, J.M.2
Preece, P.E.3
-
7
-
-
0344044332
-
A randomised, double-blind, parallel group trial to evaluate the effect of Arimidex (Anastrozole) on the pharmacokinetics of tamoxifen in postmenopausal breast cancer patients
-
Abstract 103
-
Dowsett M, Welch H, Blackman GM et al. 1997 A randomised, double-blind, parallel group trial to evaluate the effect of Arimidex (Anastrozole) on the pharmacokinetics of tamoxifen in postmenopausal breast cancer patients. Breast Cancer Research and Treatment 46 1, 30, Abstract 103.
-
(1997)
Breast Cancer Research and Treatment
, vol.461
, pp. 30
-
-
Dowsett, M.1
Welch, H.2
Blackman, G.M.3
-
8
-
-
0002048053
-
Arimidex (Anastrozole): Lack of interactions with tamoxifen, antipyrine, cimetidine and warfarin
-
Abstract 100
-
Dowsett M, Yates R & Wong YWJ 1998 Arimidex (Anastrozole): lack of interactions with tamoxifen, antipyrine, cimetidine and warfarin. European Journal of Cancer 34 (Suppl. 1) S39, Abstract 100.
-
(1998)
European Journal of Cancer
, vol.34
, Issue.1 SUPPL.
-
-
Dowsett, M.1
Yates, R.2
Wong, Y.W.J.3
-
9
-
-
0032943956
-
The effect of anastrozole on the pharmacokinetics of tamoxifen in postmenopausal women with early breast cancer
-
In Press
-
Dowsett M, Tobias JS, Howell A et al. 1999 The effect of anastrozole on the pharmacokinetics of tamoxifen in postmenopausal women with early breast cancer. British Journal of Cancer (In Press).
-
(1999)
British Journal of Cancer
-
-
Dowsett, M.1
Tobias, J.S.2
Howell, A.3
-
10
-
-
0032537396
-
Tamoxifen for early breast cancer: An overview of the randomised trials
-
Early Breast Cancer Trialists' Collaborative Group 1998 Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351 1451-1467.
-
(1998)
Lancet
, vol.351
, pp. 1451-1467
-
-
-
11
-
-
0027953320
-
Hormonal treatment for metastatic breast cancer: An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifen
-
Gale KE, Andersen JW, Tormey DC et al. 1994 Hormonal treatment for metastatic breast cancer: an Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifen. Cancer 73 354-361.
-
(1994)
Cancer
, vol.73
, pp. 354-361
-
-
Gale, K.E.1
Andersen, J.W.2
Tormey, D.C.3
-
13
-
-
0026950574
-
Aromatase inhibitors in malignant diseases of aging
-
Johanessen DC & Lonning PE 1992 Aromatase inhibitors in malignant diseases of aging. Drugs and Aging 2 530-545.
-
(1992)
Drugs and Aging
, vol.2
, pp. 530-545
-
-
Johanessen, D.C.1
Lonning, P.E.2
-
15
-
-
0026585852
-
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
-
Love RR, Mazess RB, Barden HS et al. 1992 Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. New England Journal of Medicine 326 852-856.
-
(1992)
New England Journal of Medicine
, vol.326
, pp. 852-856
-
-
Love, R.R.1
Mazess, R.B.2
Barden, H.S.3
-
16
-
-
0028000253
-
Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment
-
Love RR, Wiebe DA, Feyzi JM et al. 1994 Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment. Journal of the National Cancer Institute 86 1534-1539.
-
(1994)
Journal of the National Cancer Institute
, vol.86
, pp. 1534-1539
-
-
Love, R.R.1
Wiebe, D.A.2
Feyzi, J.M.3
-
17
-
-
0028131860
-
Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer
-
Perrez Carrion R, Alberola Candel V, Calabresi F et al. 1994 Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer. Annals of Oncology 5 (Suppl 7) 19-24.
-
(1994)
Annals of Oncology
, vol.5
, Issue.7 SUPPL.
, pp. 19-24
-
-
Perrez Carrion, R.1
Alberola Candel, V.2
Calabresi, F.3
-
18
-
-
0030070093
-
Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women
-
Powles TJ, Hickish T, Kanis JA et al. 1996 Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women. Journal of Clinical Oncology 14 78-84.
-
(1996)
Journal of Clinical Oncology
, vol.14
, pp. 78-84
-
-
Powles, T.J.1
Hickish, T.2
Kanis, J.A.3
-
19
-
-
0030801476
-
Retinal changes associated with tamoxifen treatment for breast cancer
-
Tang R, Shields J, Schiffman J et al. 1997 Retinal changes associated with tamoxifen treatment for breast cancer. Eye 11 295-297.
-
(1997)
Eye
, vol.11
, pp. 295-297
-
-
Tang, R.1
Shields, J.2
Schiffman, J.3
|